TScan Therapeutics, Inc. (TCRX)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 2 signals for TScan Therapeutics, Inc.. Most notable: 2026-09-02: Filed 8-K disclosing director or officer change; 2026-09-11: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseLynx1 Capital Management LP (ten_percent_owner) bought $68k of stock
- Insider purchaseLynx1 Capital Management LP (ten_percent_owner) bought $72k of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-23 | Lynx1 Capital Management LP | ten percent owner | P | 6,232 | 0.9 | $5,609 |
| 2025-12-22 | Lynx1 Capital Management LP | ten percent owner | P | 75,500 | 0.9 | $67,950 |
| 2025-12-19 | Lynx1 Capital Management LP | ten percent owner | P | 80,069 | 0.9 | $72,062 |
| 2025-05-20 | Lynx1 Capital Management LP | ten percent owner | P | 1,200,000 | 1.2 | $1,440,000 |
| 2025-05-19 | Lynx1 Capital Management LP | ten percent owner | P | 1,388,794 | 1.2 | $1,666,553 |
| 2024-12-13 | Nichols Weston | ten percent owner | P | 100,000 | 2.9 | $290,000 |
| 2024-12-12 | Nichols Weston | ten percent owner | P | 31,800 | 3.01 | $95,718 |
| 2024-11-15 | Nichols Weston | ten percent owner | P | 947 | 4.34 | $4,110 |
| 2024-09-23 | Klencke Barbara | director | P | 5,000 | 5.29 | $26,450 |
| 2024-08-26 | Klencke Barbara | director | P | 5,000 | 5.53 | $27,650 |
| 2024-08-23 | ZDRAVESKI ZORAN | officer | M | 54,895 | 4.85 | $266,241 |
| 2024-08-23 | ZDRAVESKI ZORAN | officer | M | 25,000 | 3.27 | $81,750 |
| 2024-08-23 | ZDRAVESKI ZORAN | officer | M | 13,125 | 1.81 | $23,756 |
| 2024-08-23 | ZDRAVESKI ZORAN | officer | M | 64,166 | 2.49 | $159,773 |
| 2024-08-23 | ZDRAVESKI ZORAN | officer | S | 164,686 | 5.78 | $951,885 |
| 2024-08-23 | Klencke Barbara | director | P | 5,000 | 5.69 | $28,450 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-11 8-K
- 2026-09-02 8-K
- 2026-08-18 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-12 10-Q
- 2026-08-12 8-K
- 2026-06-22 8-K
- 2026-05-22 4
- 2026-05-22 8-K
- 2026-05-22 4
- 2026-05-22 4
- 2026-05-22 4
- 2026-05-22 4
- 2026-05-22 4
- 2026-05-15 SCHEDULE 13G/A
- 2026-05-06 10-Q
- 2026-05-06 8-K
- 2026-04-17 ARS
- 2026-04-17 DEF 14A